We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+0.42%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$762M
Cap. Flow
+$908M
Cap. Flow %
14.82%
Top 10 Hldgs %
15.76%
Holding
794
New
208
Increased
110
Reduced
107
Closed
121

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$85M
2
ABT icon
Abbott
ABT
+$72M
3
NVDA icon
NVIDIA
NVDA
+$60.9M
4
TER icon
Teradyne
TER
+$52.2M
5
LEGN icon
Legend Biotech
LEGN
+$50.2M

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$98.7M
2
TXN icon
Texas Instruments
TXN
+$95.4M
3
GPN icon
Global Payments
GPN
+$54.3M
4
JNJ icon
Johnson & Johnson
JNJ
+$49.4M
5
KLAC icon
KLA
KLAC
+$49M

Sector Composition

Rank Sector Weight
1 Healthcare 46.26%
2 Technology 25.67%
3 Communication Services 8.98%
4 Financials 5.47%
5 Consumer Staples 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDOT
276
DELISTED
Peridot Acquisition Corp. II
PDOT
$4.37M 0.07%
450,000
– –
BBLN
277
DELISTED
Babylon Holdings Limited
BBLN
$4.33M 0.07%
+17,385
New +$4.3M
EJFA
278
DELISTED
EJF Acquisition Corp. Class A Ordinary Share
EJFA
$4.25M 0.07%
431,577
+256,577
+147% +$2.5M
SPRY icon
279
ARS Pharmaceuticals
SPRY
$530M
$4.24M 0.07%
425,261
+47,630
+13% +$1.17M
COHR
280
DELISTED
Coherent Inc
COHR
$4.24M 0.07%
+16,956
New +$4.25M
AGTI
281
DELISTED
Agiliti Inc
AGTI
$4.19M 0.07%
220,108
+91,714
+71% +$1.85M
CUE icon
282
Cue Biopharma
CUE
$116M
$4.15M 0.07%
9,504
-12,737
-57% -$4.44M
STRO icon
283
Sutro Biopharma
STRO
$431M
$4.15M 0.07%
21,951
– –
GBT
284
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.13M 0.07%
+161,940
New +$4.76M
NRIX icon
285
Nurix Therapeutics
NRIX
$2.6B
$4.12M 0.07%
+137,401
New +$4.24M
LITS
286
Lite Strategy Inc
LITS
$33M
$4.1M 0.07%
74,349
-43,682
-37% -$2.4M
RELY icon
287
Remitly
RELY
$5.12B
$4M 0.07%
+109,084
New +$4.46M
OBIO icon
288
Orchestra BioMed
OBIO
$253M
$3.99M 0.07%
403,699
– –
CHKP icon
289
Check Point Software Technologies
CHKP
$12.7B
$3.99M 0.07%
+35,299
New +$4.3M
SKINW
290
DELISTED
The Beauty Health Company Warrant expiring 5/4/2026
SKINW
$3.98M 0.07%
274,800
-725,200
-73% -$7.78M
HOOK
291
DELISTED
HOOKIPA Pharma
HOOK
$3.97M 0.06%
67,475
-22,685
-25% -$1.65M
EUSG
292
DELISTED
European Sustainable Growth Acquisition Corp. Class A Ordinary Shares
EUSG
$3.97M 0.06%
+401,427
New +$3.94M
ARYE
293
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$3.95M 0.06%
+400,000
New +$3.97M
ALT icon
294
Altimmune
ALT
$595M
$3.94M 0.06%
+348,823
New +$4.24M
DGNU
295
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$3.92M 0.06%
400,000
– –
ASZ
296
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$3.9M 0.06%
400,000
– –
HIII
297
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$3.89M 0.06%
400,000
– –
AONC
298
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$3.88M 0.06%
400,000
– –
CLAA
299
DELISTED
Colonnade Acquisition Corp. II
CLAA
$3.78M 0.06%
386,122
– –
DNTH icon
300
Dianthus Therapeutics
DNTH
$6.09B
$3.75M 0.06%
+32,229
New +$3.75M
10 11
12
13 14

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Woodline Partners held 794 positions worth $6.12B, up 14% from $5.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $908M of net new capital in Q3 2021, opening 208 new positions and adding to 110 existing holdings. Its largest new stake was Qualcomm: 599,018 shares worth $77.3M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amphenol, an estimated $98.7M trimmed.

  • Woodline Partners's largest Q3 2021 buy was Qualcomm: 599,018 shares worth $77.3M.
  • Woodline Partners added most to Teradyne in Q3 2021, an estimated $52.2M increase.
  • Woodline Partners's biggest Q3 2021 reduction was Amphenol, cutting an estimated $98.7M.
  • Woodline Partners fully exited Boston Scientific in Q3 2021, selling an estimated $44.9M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.12B portfolio in Q3 2021.
  • Woodline Partners opened 208 new positions and closed 121 in Q3 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.12B.

Based on Woodline Partners's 13F filing for Q3 2021, filed 15 Nov 2021.